This disease can be divided into estrogen receptor (ER)-positive or (ER)-negative breast cancer and further into several subtypes depending on the presence of other biomarkers such as human epidermal growth factor receptor 2 (HER2) or progesterone receptors. This evidence concerns the gene ESR1 and breast cancer.